• LAST PRICE
    65.0000
  • TODAY'S CHANGE (%)
    Trending Up1.6700 (2.6370%)
  • Bid / Lots
    26.6800/ 2
  • Ask / Lots
    106.6800/ 2
  • Open / Previous Close
    63.4100 / 63.3300
  • Day Range
    Low 63.4100
    High 67.4400
  • 52 Week Range
    Low 25.6000
    High 77.6000
  • Volume
    666,440
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 63.33
TimeVolumeIRON
09:32 ET102763.41
09:35 ET30064.43
09:42 ET10064.86
09:46 ET46065.2599
09:50 ET20065
09:51 ET10064.12
09:53 ET20064.835
10:02 ET4404265.665
10:04 ET826865.175
10:06 ET281765.22
10:08 ET2622965.515
10:09 ET965765.32
10:11 ET1541965.25
10:13 ET3531065.505
10:15 ET351666
10:18 ET1313865.94
10:20 ET399965.75
10:22 ET1119965.71
10:24 ET782865.51
10:26 ET49965.42
10:27 ET85265.1701
10:29 ET1132465.6
10:31 ET1065165.55
10:33 ET2170065.43
10:36 ET843065.15
10:38 ET20065.28
10:40 ET66865.22
10:42 ET78565.15
10:44 ET20065.23
10:54 ET20565.2
10:58 ET323665.23
11:05 ET1232765.15
11:07 ET145065.14
11:09 ET82864.89
11:12 ET10064.975
11:16 ET80065.175
11:18 ET370065.46
11:21 ET40965.25
11:27 ET130065.25
11:30 ET221165.135
11:32 ET20065.0457
11:34 ET90065.08
11:38 ET30065.405
11:39 ET210065.415
11:43 ET10065.44
11:45 ET40965.17
11:48 ET30065.25
11:56 ET310065.295
11:59 ET124665
12:03 ET20065.275
12:12 ET10065.22
12:14 ET30064.98
12:15 ET14565.2071
12:17 ET21065.075
12:19 ET80065.23
12:21 ET10065.11
12:24 ET30065.315
12:26 ET10065.265
12:30 ET20065.11
12:32 ET10065.05
12:35 ET10065.13
12:37 ET30065.25
12:39 ET10065.05
12:42 ET40065.145
12:46 ET30065.105
12:50 ET20065.195
12:51 ET190065.125
12:55 ET20065.17
01:00 ET30065.05
01:04 ET26065.175
01:06 ET10065.14
01:09 ET40065.12
01:20 ET20065
01:31 ET20065.025
01:33 ET157165.27
01:36 ET198065.13
01:38 ET20165.13
01:40 ET80065.2
01:42 ET10065.06
01:45 ET106465.19
01:47 ET110065.16
01:51 ET809665.235
01:54 ET80065.12
01:58 ET20065.12
02:02 ET100265.01
02:03 ET50065.05
02:05 ET10065.05
02:07 ET10064.965
02:09 ET10065.0646
02:12 ET30065
02:18 ET25665
02:21 ET414465.045
02:23 ET197364.98
02:25 ET40064.95
02:27 ET42264.965
02:30 ET10065
02:32 ET20064.965
02:34 ET10064.92
02:38 ET20064.99
02:39 ET843265.01
02:41 ET811865.01
02:43 ET224265.03
02:45 ET500265.25
02:48 ET110065.19
02:50 ET153165.395
02:52 ET30065.47
02:56 ET279665.33
02:57 ET20065.44
02:59 ET70065.385
03:01 ET74465.4
03:03 ET240065.32
03:06 ET260065.565
03:08 ET120065.72
03:10 ET60065.7
03:12 ET159965.82
03:14 ET20065.685
03:15 ET210066.025
03:17 ET439667.0058
03:19 ET163367.2857
03:21 ET285067.15
03:24 ET30067.145
03:26 ET10067.22
03:28 ET64967.01
03:30 ET90066.56
03:32 ET80066.42
03:33 ET279066.495
03:35 ET2444766.38
03:37 ET3310265.8
03:39 ET157166.06
03:42 ET320065.64
03:44 ET272365.82
03:46 ET139765.84
03:48 ET167765.61
03:50 ET240065.55
03:51 ET304765.51
03:53 ET510065.485
03:55 ET491465.48
03:57 ET512765.04
04:00 ET5407665
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIRON
Disc Medicine Inc
1.9B
-17.8x
---
United StatesVRDN
Viridian Therapeutics Inc
1.9B
-5.9x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
1.9B
-6.0x
---
United StatesSYRE
Spyre Therapeutics Inc
2.0B
-2.6x
---
United StatesTARS
Tarsus Pharmaceuticals Inc
1.9B
-11.2x
---
United StatesCNTA
Centessa Pharmaceuticals PLC
2.1B
-10.6x
---
As of 2024-11-10

Company Information

Disc Medicine, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps) including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Contact Information

Headquarters
321 Arsenal Street, Suite 101WATERTOWN, MA, United States 02472
Phone
617-674-9274
Fax
302-655-5049

Executives

Executive Chairman of the Board
Donald Nicholson
President, Chief Executive Officer, Director
John Quisel
Chief Financial Officer, Treasurer
Jean Franchi
Chief Operating Officer
Jonathan Yu
General Counsel
Rahul Khara

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9B
Revenue (TTM)
$0.00
Shares Outstanding
29.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.73
EPS
$-3.66
Book Value
$14.17
P/E Ratio
-17.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.